Melissa Hunter-Ensor, Ph.D.

Experience: Patent Portfolio Management and Strategic Counseling: Devised a strategy for protecting and licensing a novel nucleic acid amplification method resulting in patent grant in the U.S. and numerous international jurisdictions in under two years.; Developed a worldwide IP portfolio for a privately held company for a biologic agent that was granted an emergency exemption by the Environmental Protection Agency for use in 17 states.; Developed a world-wide IP portfolio prosecution strategy for a public company that resulted in patent protection for Alzheimer's disease, lung cancer, ovarian cancer and peripheral artery disease diagnostics.; Crafted an international strategy resulting in granted patents for a local drug delivery device that is in clinical use.; Technology Transactions and Licensing: A key member of a team assisting a Japanese pharmaceutical company with IP Iicensing due diligence that formed the basis for a multi-billion dollar acquisition of a publicly held biotechnology company.; Conducted a patent landscape analysis on behalf of multiple university clients that informed their licensing negotiations with venture capital investors resulting in the successful formation of a university-licensed start-up.; Advised an international pharmaceutical company in licensing exclusive, worldwide rights for research, development, manufacturing and commercialization of a polynucleotide-based therapeutic.; Litigation and Pre-Litigation Strategy: Advised a publicly held pharmaceutical company in evaluating whether internet sales of a small molecule pharmaceutical product were exempt from infringement under the safe harbor provided by U.S.C. 271(e)(1).; Represented the General Hospital Corporation in an inventorship dispute that resulted in summary judgment for the hospital, which was affirmed by the Court of Appeals for the Federal Circuit.; Represented a university in an inventorship dispute that involved undergraduate research.; Worked with the university's general counsel to revise the institution's Intellectual Property Policy with regard to undergraduate researchers.; The above representations were handled by Dr. Hunter-Ensor prior to her joining Greenberg Traurig, LLP.